Current opinion in obstetrics & gynecology
-
Curr. Opin. Obstet. Gynecol. · Dec 2010
ReviewA review of obstetric anesthesia in the new millennium: where we are and where is it heading?
The present article is an update on the state-of-the-art practice of obstetric anesthesia in the new millennium. It explores a number of important issues in this relatively new and still evolving subspecialty of anesthesiology. ⋯ Changes in maternal-fetal and neonatal medicine and obstetric anesthesia have been developing rapidly during the recent years and will continue to do so in the years to come. Obstetric anesthesia is art and science combined. An obstetric anesthesiologist is concerned simultaneously with the lives of at least two patients - the mother and her child. Exchange of information and communication skills in the ever changing environment of labor and delivery is essential for perfect outcome, which is always expected when providing passage for the mother and her baby from the antepartum to postpartum period.
-
Curr. Opin. Obstet. Gynecol. · Oct 2010
ReviewThe use of infection prevention practices in female pelvic medicine and reconstructive surgery.
This review discusses recently published and relevant data on the preventive techniques used to reduce perioperative infections in urogynecologic procedures. ⋯ Good evidence-based practices to reduce or prevent infectious complications after procedures in female urology and urogynecology will save time, lower morbidity, reduce costs, and improve patient outcomes and satisfaction. However, there is still a great need for more level I evidence on infection prevention practices utilized in female urology and urogynecology.
-
Cesarean section is the most common surgical procedure performed on US women, and rates of cesarean delivery continue to increase. ⋯ It is imperative that all technical aspects in cesarean section continue to be challenged. Widely accepted aspects, including antibiotics administration at cord clamping and creation of a bladder flap, may not be best practice.
-
Curr. Opin. Obstet. Gynecol. · Feb 2010
ReviewDuration of adjuvant endocrine therapy of breast cancer: how much is enough?
To describe the current status regarding the duration of adjuvant tamoxifen and/or aromatase inhibitors in women with early-stage hormone receptor positive breast cancer. ⋯ There are many approaches to the adjuvant hormonal therapy of breast cancer supported by large trials. No one approach is uniquely superior to others. Longer follow-up may lead to more specific recommendations. Adjuvant hormonal therapy for women with hormone receptor positive breast cancer plays a critical role in the management of early stage hormone receptor positive breast cancer.